Public
All

ST PHARM's Public Release

ST PHARM NewsST Pharm Showcases New CRISPR Therapeutic Platforms at CRISPR Medicines 2025Apr 9, 2025
ST PHARM NewsST PHARM Participates in DCAT Week 2025, Seeking Global PartnershipsMar 21, 2025
ST PHARM NewsThe SMARTCAP® patent was granted in JapanMar 18, 2025
ST PHARM NewsUSPTO grants patent to Vernagen's mRNA-Based RSV A/B VaccineMar 11, 2025
ST PHARM NewsST PHARM 'Basroparib' Combination Therapy Preclinical Result PublishedMar 5, 2025
ST PHARM News[Notice] ST Pharm Completes Trademark Registration for Proprietary mRNA Platform Core Technologies (SMARTCAP® & STLNP®)Mar 4, 2025
ST PHARM NewsST Pharm and Evonik Collaborate to Advance mRNA Therapeutics through PartnershipJan 10, 2025
ST PHARM NewsST Pharm to Present Basroparib (STP1002) at ESMO Congress 2024Sep 6, 2024
ST PHARM NewsST Pharm Banwol Campus Awarded EcoVadis 'Gold' MedalSep 6, 2024
ST PHARM NewsST Pharm, honored with two awards at the ‘Korea Biopharma Excellence Awards 2024’Aug 19, 2024
ST PHARM NewsST PHARM's Participation in 2024 DCAT Week Highlights Innovation in Pharmaceutical SectorMar 20, 2024
ST PHARM News[Notice] RNA Innovation Symposium Corea/Korea 2024 (RISC 2024)Feb 26, 2024
ST PHARM NewsST PHARM, Pirmitegravir (STP0404), HIV: Three trials to watch in 2024Jan 15, 2024
1of5
HOMEPublicPR (Public Relations)News roomAll
© 2025 ST Pharm. All rights reserved.